Discontinuing treatment for 0.5 years was associated with increased risk for major adverse cardiovascular events.

The Food and Drug Administration (FDA) has extended the review period for Orca-T in the treatment of patients with ...

HealthDay News — Kratom-related reports to poison centers are increasing, especially among certain demographic groups, according to research published in the March 26 issue of the US Centers for ...

Postmarketing reports of fatal liver injury associated with avacopan have prompted the FDA to issue a safety alert and ...

Supplemental New Drug Application for at-home Igalmi aims to provide a self-administered option for agitation in schizophrenia and bipolar disorder.

Investigators sought to identify risks of prescription drug promotion by social media influencers and how current evidence can inform future research and effective policy ...

In phase 3 clinical trials, orforglipron was associated with significant reductions in mean percent body weight compared with placebo in patients with and without type 2 diabetes.

The US Food and Drug Administration (FDA) is considering whether to allow new ingredients in dietary supplements. The move could eventually expand the range of products marketed for things like muscle ...

SUPER-1 evaluated GZR4 in insulin-naïve Chinese adults with T2DM, while SUPER-2 assessed those previously treated with basal insulin.

The potential health impacts of low-to-moderate alcohol intake appear to vary by beverage type, according to a study ...

Relutrigine, a novel sodium channel modulator, is under FDA Priority Review for the treatment of pediatric SCN2A and SCN8A epileptic encephalopathies.

People residing in Birmingham, Alabama, recently learned that their drinking water would no longer contain fluoride. But there was a bigger surprise. It turns out fluoride had already been removed ...